TVTX Operating Cash Flow (Statement)
Travere Therapeutics Inc · Operating Cash Flow (Statement)
TVTX Operating Cash Flow (Statement)
Latest reported$92.70Mperiod ending
TVTX Cash from Operations (-$18.27K → $92.70M)
Annual operating cash flow (statement)
High-resolution chart · PNG
TVTX operating cash flow (statement) history
Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Operating Cash Flow (Statement) (USD) |
|---|---|
| 37,784,000 | |
| -237,475,000 | |
| -280,021,000 | |
| -186,291,000 | |
| -14,792,000 | |
| -42,743,000 | |
| -58,214,000 | |
| -24,958,000 | |
| 7,403,000 | |
| -1,596,000 | |
| -554,000 | |
| -45,849,750 | |
| -17,589,168 | |
| -2,736,739 | |
| -49 | |
| -689 | |
| -15,478 | |
| -18,266 |